Allgemein

PL BioScience Reveals Fall 2025 Conferences Attendance PL BioScience announces participation in upcoming conferences this fall PL BioScience has revealed its participation in six upcoming Fall 2025 conferences. As part of its global strategy, the company will be represented in the following conferences in Asia and Europe:

READ MORE

Becoming human: GMP-compliant supplements for cell therapy We were recently interviewed by European biotech media company Labiotech regarding our thoughts on cell culture reagent challenges, and our line of ELAREM™ Human Platelet Lysate (HPL) for cell therapy. The article features thoughts and quotes from CEO &

READ MORE

A new publication from Kouroupis et al. published in CYTOTHERAPY in July 2020 found out that infrapatellar fat pad (IFP)-mesenchymal stem cells (MSCs) manufactured with human Platelet Lysate (hPL) show enhanced immunomodulatory properties. Findings have potential for a minimally invasive cell therapy for joint disease The authors even

READ MORE
Any questions?
close slider

Any questions?

Please contact us:

support@pl-bioscience.com

+49 (0) 241 95719-100